270
Views
16
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH ARTICLES

Characterization of the Zebrafish atxn1/axh Gene Family

, , , , &
Pages 313-323 | Received 02 Feb 2008, Published online: 01 Sep 2009

References

  • Bowman A. B., Lam Y. C., Jafar-Nejad P., Chen H. K., Richman R., Samaco R. C., Fryer J. D., Kahle J. J., Orr H. T., Zoghbi H. Y. Duplication of Atxn1l suppresses SCA1 neuropathology by decreasing incorporation of polyglutamine-expanded ataxin-1 into native complexes. Nat. Genet 2007; 39: 373–379
  • Burright E. N., Clark H. B., Servadio A., Matilla T., Feddersen R. M., Yunis W. S., Duvick L. A., Zoghbi H. Y., Orr H. T. SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat. Cell 1995; 82: 937–948
  • Chen H. K., Fernandez-Funez P., Acevedo S. F., Lam Y. C., Kaytor M. D., Fernandez M. H., Aitken A., Skoulakis E. M., Orr H. T., Botas J., Zoghbi H. Y. Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1. Cell 2003; 113: 457–468
  • Chen Y. W., Allen M. D., Veprintsev D. B., Lowe J., Bycroft M. The structure of the AXH domain of spinocerebellar ataxin-1. J. Biol. Chem 2004; 279: 3758–3765
  • de Chiara C., Giannini C., Adinolfi S., de Boer J., Guida S., Ramos A., Jodice C., Kioussis D., Pastore A. The AXH module: an independently folded domain common to ataxin-1 and HBP1. FEBS Lett 2003; 551: 107–112
  • Emamian E. S., Kaytor M. D., Duvick L. A., Zu T., Tousey S. K., Zoghbi H. Y., Clark H. B., Orr H. T. Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice. Neuron 2003; 38: 375–387
  • Kaytor M. D., Byam C. E., Tousey S. K., Stevens S. D., Zoghbi H. Y., Orr H. T. A cell-based screen for modulators of ataxin-1 phosphorylation. Hum. Mol. Genet 2005; 14: 1095–1105
  • Kimmel C. B., Ballard W. W., Kimmel S. R., Ullmann B., Schilling T. F. Stages of embryonic development of the zebrafish. Dev. Dyn 1995; 203: 253–310
  • Klement I. A., Skinner P. J., Kaytor M. D., Yi H., Hersch S. M., Clark H. B., Zoghbi H. Y., Orr H. T. Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell 1998; 95: 41–53
  • Lam Y. C., Bowman A. B., Jafar-Nejad P., Lim J., Richman R., Fryer J. D., Hyun E. D., Duvick L. A., Orr H. T., Botas J., Zoghbi H. Y. ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology. Cell 2006; 127: 1335–1347
  • Lieschke G. J., Currie P. D. Animal models of human disease: zebrafish swim into view. Nat. Rev. Genet 2007; 8: 353–367
  • Matilla A., Roberson E. D., Banfi S., Morales J., Armstrong D. L., Burright E. N., Orr H. T., Sweatt J. D., Zoghbi H. Y., Matzuk M. M. Mice lacking ataxin-1 display learning deficits and decreased hippocampal paired-pulse facilitation. J. Neurosci 1998; 18: 5508–5516
  • Miller V. M., Nelson R. F., Gouvion C. M., Williams A., Rodriguez-Lebron E., Harper S. Q., Davidson B. L., Rebagliati M. R., Paulson H. L. CHIP suppresses polyglutamine aggregation and toxicity in vitro and in vivo. J. Neurosci 2005; 25: 9152–9161
  • Miyamura Y., Nakayasu H. Zonal distribution of Purkinje cells in the zebrafish cerebellum: analysis by means of a specific monoclonal antibody. Cell Tissue Res 2001; 305: 299–305
  • Mizutani A., Wang L., Rajan H., Vig P. J., Alaynick W. A., Thaler J. P., Tsai C. C. Boat, an AXH domain protein, suppresses the cytotoxicity of mutant ataxin-1. Embo. J 2005; 24: 3339–3351
  • Mushegian A. R., Bassett D. E., Jr, Boguski M. S., Bork P., Koonin E. V. Positionally cloned human disease genes: patterns of evolutionary conservation and functional motifs. Proc Natl Acad Sci U S A 1997; 94: 5831–5836
  • Nakamura K., Jeong S. Y., Uchihara T., Anno M., Nagashima K., Nagashima T., Ikeda S., Tsuji S., Kanazawa I. SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. Hum. Mol. Genet 2001; 10: 1441–1448
  • Orr H. T., Chung M. Y., Banfi S., Kwiatkowski T. J., Jr, Servadio A., Beaudet A. L., McCall A. E., Duvick L. A., Ranum L. P., Zoghbi H. Y. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat. Genet 1993; 4: 221–226
  • Serra H. G., Duvick L., Zu T., Carlson K., Stevens S., Jorgensen N., Lysholm A., Burright E., Zoghbi H. Y., Clark H. B., Andresen J. M., Orr H. T. RORalpha-mediated Purkinje cell development determines disease severity in adult SCA1 mice. Cell 2006; 127: 697–708
  • Servadio A., Koshy B., Armstrong D., Antalffy B., Orr H. T., Zoghbi H. Y. Expression analysis of the ataxin-1 protein in tissues from normal and spinocerebellar ataxia type 1 individuals. Nat. Genet 1995; 10: 94–98
  • Subramony, S. H. and. Vig, P. J. 1998. Clinical aspects of spinocerebellar ataxia. In, R. D. Wells, S. T. Warren, Genetic instabilities and hereditary neurological diseases. 231–239. San Diego: Academic Press.
  • Taylor J. S., Braasch I., Frickey T., Meyer A., Van de Peer Y. Genome duplication, a trait shared by 22000 species of ray-finned fish. Gen. Res 2003; 13: 382–390
  • Tsai C. C., Kao H. Y., Mitzutani A., Banayo E., Rajan H., McKeown M., Evans R. M. Ataxin 1, a SCA1 neurodegenerative disorder protein, is functionally linked to the silencing mediator of retinoid and thyroid hormone receptors. Proc. Natl. Acad, Sci. U. S. A. 2004; 101: 4047–4052
  • Tsuda H., Jafar-Nejad H., Patel A. J., Sun Y., Chen H. K., Rose M. F., Venken K. J., Botas J., Orr H. T., Bellen H. J., Zoghbi H. Y. The AXH domain of Ataxin-1 mediates neurodegeneration through its interaction with Gfi-1/Senseless proteins. Cell 2005; 122: 633–644
  • Vierra-Green C. A., Orr H. T., Zoghbi H. Y., Ferrington D. A. Identification of a novel phosphorylation site in ataxin-1. Biochim. Biophys. Acta 2005; 1744: 11–118
  • Wullimann, M. F, R. B. a. R. H. 1996. Neuroanatomy of the Zebrafish Brain: A Topological Atlas. Basel, BostonBerlin: Birkhauser Verlag.
  • Zoghbi H. Y., Orr H. T. Glutamine repeats and neurodegeneration. Annu. Rev. Neurosci 2000; 23: 217–247
  • Zon L. I., Peterson R. T. In vivo drug discovery in the zebrafish. Nat. Rev. Drug Discov 2005; 4: 35–44

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.